RING-finger type E3 ubiquitin ligase inhibitors as novel candidates for the treatment of rheumatoid arthritis.
RING-finger type E3 ubiquitin ligase inhibitors as novel candidates for the treatment of rheumatoid arthritis.
复制标题
DOI:
10.3892/ijmm.2012.1129
复制
发表时间:
2012-12
影响因子:
5.4
通讯作者:
Nakajima T
中科院分区:
文献类型:
--
作者:
Yagishita N;Aratani S;Leach C;Amano T;Yamano Y;Nakatani K;Nishioka K;Nakajima T
Rheumatoid arthritis (RA) significantly affects quality of life. We recently cloned synoviolin, a RING-type E3 ubiquitin ligase implicated in the endoplasmic reticulum-associated degradation (ERAD) pathway. Synoviolin is highly expressed in rheumatoid synovial cells and may be involved in the pathogenesis of RA. Inhibition of synoviolin activity is a potentially useful therapeutic approach for the treatment of RA. We conducted a high-throughput screen of small molecules to find inhibitors of synoviolin autoubiquitination activity. We identified two classes of small molecules, named LS-101 and LS-102, which inhibited synoviolin activity. LS-102 selectively inhibited synoviolin enzymatic activity, while LS-101 inhibited a broad array of RING-type E3 ligases. Moreover, these inhibitors suppressed the proliferation of rheumatoid synovial cells, and significantly reduced the severity of disease in a mouse model of RA. Our results suggest that inhibition of synoviolin is a potentially useful approach in the treatment of RA.
登录
查看更多内容
影响因子:
3.7
作者:
Hasegawa D;Fujii R;Yagishita N;Matsumoto N;Aratani S;Izumi T;Azakami K;Nakazawa M;Fujita H;Sato T;Araya N;Koike J;Tadokoro M;Suzuki N;Nagata K;Senoo H;Friedman SL;Nishioka K;Yamano Y;Itoh F;Nakajima T
通讯作者:
Nakajima T
影响因子:
4.8
作者:
Hashizume, R;Fukuda, M;Ohta, T
通讯作者:
Ohta, T
影响因子:
4.8
作者:
Moynihan, TP;Ardley, HC;Robinson, PA
通讯作者:
Robinson, PA
影响因子:
11.5
作者:
Nurmohamed, Michael T.
通讯作者:
Nurmohamed, Michael T.
影响因子:
10.5
作者:
Amano, T;Yamasaki, S;Nakajima, T
通讯作者:
Nakajima, T